Stock ALKEM ALKEM LABORATORIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Alkem Laboratories Limited

Equities

ALKEM

INE540L01014

Market Closed - NSE India S.E.
Other stock markets
 12:43:51 15/05/2024 BST 		5-day change 1st Jan Change
5,247 INR +1.23% Intraday chart for Alkem Laboratories Limited +1.61% +0.85%
04-16 Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak CI
03-28 Alkem Laboratories Forms Subsidiary for Medical Devices Business MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biosergen receives regulatory approval to test lead candidate BSG005 in patients with invasive fungal infection.
AQ
Research Update Biosergen: Licensing deal with Alkem and CTA submission
AQ
Biosergen's Partner Alkem Laboratories Submits Clinical Trial Application for First Patient Study with BSG005 in Invasive Fungal Infections in India as a Rescue Therapy
AQ
Biosergen and Alkem Laboratories Ltd collaborates to develop anti-infective for severe fungal infections
AQ
Alkem Subsidiary Enzene Launches Adalimumab Biosimilar In India
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALKEM Stock
  4. News Alkem Laboratories Limited
  5. Press Releases